New hope for tough childhood cancers: first trial of Triple-Drug attack
NCT ID NCT02298348
Summary
This study is testing a new combination of three drugs for children and young adults whose neuroblastoma has returned or hasn't responded to standard treatments. The main goal is to find the highest dose of a drug called sorafenib that can be safely added to two other chemotherapy drugs. This is the first step to see if this three-drug approach is safe and could be more effective against this aggressive childhood cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
C.S Mott Children's Hospital
Ann Arbor, Michigan, 48109, United States
-
Children Hospital of Colorado
Aurora, Colorado, 80045, United States
-
Children's Healthcare of Atlanta
Atlanta, Georgia, 30322, United States
-
Children's Hospital Los Angeles
Los Angeles, California, 90027-0700, United States
-
Children's Hospital and Regional Medical Center - Seattle
Seattle, Washington, 98105, United States
-
Childrens Hospital Boston, Dana-Farber Cancer Institute.
Boston, Massachusetts, 02115, United States
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229-3039, United States
-
Cook Children's Healthcare System
Fort Worth, Texas, 76104, United States
-
Hospital for Sick Children
Toronto, Ontario, M5G 1X8, Canada
-
UCSF Comprehensive Cancer Center
San Francisco, California, 94143, United States
-
University of Chicago, Comer Children's Hospital
Chicago, Illinois, 60637, United States
-
University of North Carolina
Chapel Hill, North Carolina, 27599, United States
Conditions
Explore the condition pages connected to this study.